RFC
ARRY

Russell Frank Company’s Array Biopharma Inc ARRY Stock Holding History

Russell Frank Company’s Portfolio ARRY Stock Details ARRY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q2 		– Sell
-129,157
Closed -$952K – 3122
2015
Q1 		$952K Buy
+129,157
New +$919K ﹤0.01% 2167
2013
Q4 		– Sell
-26,839
Closed -$167K – 3205
2013
Q3 		$167K Buy
26,839
+71
+0.3% +$422 ﹤0.01% 2813
2013
Q2 		$122K Buy
+26,768
New +$144K ﹤0.01% 2690

Other funds holding ARRY

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Russell Frank Company's ARRY Position: Q2 2015 in Review

Russell Frank Company sold out of Array Biopharma Inc (ARRY) in Q2 2015, closing a stake of 129,157 shares — an estimated $952K sold.

Russell Frank Company first reported a position in ARRY in Q2 2013 and held it in 3 quarters. The position peaked at $952K in Q1 2015. 148 funds tracked by Wall St. Rank hold ARRY as of Q2 2015.

  • Russell Frank Company reported no remaining Array Biopharma Inc position as of Q2 2015 after selling out during the quarter.
  • Russell Frank Company sold 129,157 Array Biopharma Inc shares in Q2 2015, an estimated $952K.
  • Russell Frank Company first reported a position in Array Biopharma Inc in Q2 2013 and held it in 3 quarters.
  • Russell Frank Company's Array Biopharma Inc position peaked at $952K in Q1 2015.
  • 148 funds tracked by Wall St. Rank held Array Biopharma Inc as of Q2 2015.

Based on Russell Frank Company's 13F filing for Q2 2015, filed 13 Aug 2015.